Related Experiment Video
Updated: Aug 12, 2026

08:20
Cell Block Preparation from Cytology Specimen with Predominance of Individually Scattered Cells
Published on: July 21, 2009
Diagnostic Usefulness of Cell Block Samples in Fluid Overload-Associated Large B-Cell Lymphoma
Hiroyuki Okanishi1, Hiroko Kuwabara1, Hiroko Nakayama1
1Division of Diagnostic Pathology, Osaka Medical and Pharmaceutical University Hospital, Osaka, Japan.
Diagnostic Cytopathology
|August 11, 2026
Summary
Fluid overload-associated B-cell lymphoma (FO-LBCL) is a rare cancer presenting in effusions. This case highlights successful chemotherapy treatment and diagnosis via cytology and immunohistochemistry.
Area of Science:
- Hematology
- Oncology
- Pathology
Background:
- Fluid overload-associated B-cell lymphoma (FO-LBCL) is a distinct B-cell neoplasm.
- It characteristically presents as serous effusions without solid tumor masses.
- FO-LBCL is typically negative for Kaposi sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8 (HHV8).
Purpose of the Study:
- To report a case of FO-LBCL in an 81-year-old female patient.
- To detail the diagnostic approach using cytological and immunohistochemical analysis.
- To illustrate the effectiveness of systemic chemotherapy in achieving remission.
Main Methods:
- Cytological examination of pericardial and pleural effusions.
- Immunohistochemical analysis of a pleural fluid cell block.
- Clinical and imaging findings assessment.
- Systemic chemotherapy administration.
Main Results:
- Cytology revealed medium- to large-sized atypical lymphoid cells.
- Immunohistochemistry confirmed CD20 and CD79a positivity, and negativity for CD3, KSHV/HHV-8, and Epstein-Barr virus.
- The Ki-67 labeling index was high at 95%.
- The patient achieved complete remission with no recurrence over a 3-year follow-up.
Conclusions:
- FO-LBCL diagnosis relies on cytological, clinical, and imaging data.
- Immunohistochemical analysis of cell blocks is crucial for accurate diagnosis and treatment planning.
- Systemic chemotherapy is an effective treatment modality for FO-LBCL.

